BAX vs. RMD: Baxter vs. ResMed Stock Comparison
How do Baxter (BAX) and ResMed (RMD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Baxter (BAX) and ResMed (RMD) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | BAX | RMD |
|---|---|---|
| Name | Baxter International Inc. | ResMed Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 13.34 billion USD | 33.10 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | October 27, 1981 | June 2, 1995 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | BAX | RMD |
|---|---|---|
| Total Return (1Y) | 45.72% | -5.42% |
| Total Return (3Y, Annualized) | -5.53% | 18.99% |
| Total Return (5Y, Annualized) | -17.96% | -1.23% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | BAX | RMD |
|---|---|---|
| Volatility (1Y, Annualized) | 42.31% | 30.80% |
| Beta (5Y) | 0.62 | 0.75 |
| Max Drawdown (5Y) | -80.61% | -49.04% |
| Avg. Volume (3M) | 6.53M | 1.32M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | BAX | RMD |
|---|---|---|
| Sharpe Ratio (1Y) | 0.98 | -0.31 |
| Sortino Ratio (1Y) | 1.42 | -0.43 |
Profitability
ROE (TTM)
Baxter (BAX) reports a negative ROE of -9.04%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile ResMed (RMD) reports 26.40%, ranking against industry peers normally.
BAX
Health Care Equipment & Services industry group
-9.04%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- BAX
- -9.04%
- Q1
- -10.67%
- Min
- -47.01%
RMD
Health Care Equipment & Services industry group
26.40%
- Max
- 47.61%
- RMD
- 26.40%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Baxter (BAX) reports a negative net margin of -6.23%, usually indicating a net loss over the period. Meanwhile ResMed (RMD) reports 27.79%, ranking against industry peers normally.
BAX
Health Care Equipment & Services industry group
-6.23%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- BAX
- -6.23%
- Q1
- -6.29%
- Min
- -28.46%
RMD
Health Care Equipment & Services industry group
27.79%
- Max
- 29.35%
- RMD
- 27.79%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
ResMed (RMD) at 34.82% operates in the top operating margin quartile, ahead of Baxter (BAX) at 9.88%, which runs around its industry’s norm.
BAX
Health Care Equipment & Services industry group
9.88%
- Max
- 35.43%
- Q3
- 14.14%
- BAX
- 9.88%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
RMD
Health Care Equipment & Services industry group
34.82%
- Max
- 35.43%
- RMD
- 34.82%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | BAX | RMD |
|---|---|---|
| ROE (TTM) | -9.04% | 26.40% |
| ROA (TTM) | 2.71% | 14.76% |
| Net Margin (TTM) | -6.23% | 27.79% |
| Operating Margin (TTM) | 9.88% | 34.82% |
| Gross Margin (TTM) | 33.37% | 61.77% |
Growth
Revenue Growth
Both Baxter (BAX) at 5.72% and ResMed (RMD) at 9.85% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Neither Baxter (BAX) nor ResMed (RMD) reports a EPS growth value for this period, so a direct comparison isn't possible.
Growth Metrics
| Metric | BAX | RMD |
|---|---|---|
| Revenue Growth (YoY) | 5.72% | 9.85% |
| Revenue Growth (3Y CAGR) | 3.79% | 10.21% |
| EPS Growth (YoY) | -- | -- |
| EPS Growth (3Y CAGR) | -- | 19.64% |
Financial Strength
Current Ratio (MRQ)
Both Baxter (BAX) at 1.79 and ResMed (RMD) at 2.65 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.
BAX
Health Care Equipment & Services industry group
1.79
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- BAX
- 1.79
- Q1
- 1.37
- Min
- 0.30
RMD
Health Care Equipment & Services industry group
2.65
- Max
- 7.59
- Q3
- 4.00
- RMD
- 2.65
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
ResMed (RMD) at 0.10 keeps leverage in the lower quartile, while Baxter (BAX) at 1.36 sits in the higher-leverage quartile.
BAX
Health Care Equipment & Services industry group
1.36
- Max
- 1.88
- BAX
- 1.36
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
RMD
Health Care Equipment & Services industry group
0.10
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- RMD
- 0.10
- Min
- 0.00
Financial Strength Metrics
| Metric | BAX | RMD |
|---|---|---|
| Current Ratio (MRQ) | 1.79 | 2.65 |
| Debt / Equity (MRQ) | 1.36 | 0.10 |
| Net Debt / EBITDA | 3.73 | -0.19 |
Dividends
Dividend Yield (TTM)
Both Baxter (BAX) at 0.16% and ResMed (RMD) at 1.03% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.
BAX
Health Care Equipment & Services industry group
0.16%
- BAX
- 0.16%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
RMD
Health Care Equipment & Services industry group
1.03%
- RMD
- 1.03%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Baxter (BAX) reports payout ratio above 100% at 154.67%, meaning dividends exceeded current-period earnings and sustainability needs extra context. Meanwhile ResMed (RMD) reports 22.40%, ranking against industry peers normally.
BAX
Health Care Equipment & Services industry group
154.67%
- BAX
- 154.67%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
RMD
Health Care Equipment & Services industry group
22.40%
- RMD
- 22.40%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | BAX | RMD |
|---|---|---|
| Dividend Yield (TTM) | 0.16% | 1.03% |
| Dividend Payout Ratio (TTM) | 154.67% | 22.40% |
Valuation
P/E Ratio (TTM)
An earnings multiple is available for just one side: ResMed (RMD) trades at 21.43 times trailing earnings, ranked against its peers, while Baxter (BAX) has no P/E ratio this period.
BAX
Health Care Equipment & Services industry group
--
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
- BAX
- --
RMD
Health Care Equipment & Services industry group
21.43
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- RMD
- 21.43
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Baxter (BAX) at 1.15 is priced about in line with its industry on P/S ratio, while ResMed (RMD) at 5.77 sits in the pricier quartile — RMD costs more per dollar of sales.
BAX
Health Care Equipment & Services industry group
1.15
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- BAX
- 1.15
- Q1
- 1.10
- Min
- 0.03
RMD
Health Care Equipment & Services industry group
5.77
- Max
- 8.80
- RMD
- 5.77
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
On P/B ratio, both Baxter (BAX) at 2.05 and ResMed (RMD) at 5.56 are valued close to their industries’ norm against book — neither stands out from peers.
BAX
Health Care Equipment & Services industry group
2.05
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- BAX
- 2.05
- Q1
- 1.73
- Min
- -1.31
RMD
Health Care Equipment & Services industry group
5.56
- Max
- 11.68
- Q3
- 6.12
- RMD
- 5.56
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | BAX | RMD |
|---|---|---|
| P/E Ratio (TTM) | -- | 21.43 |
| P/S Ratio (TTM) | 1.15 | 5.77 |
| P/B Ratio (MRQ) | 2.05 | 5.56 |
| Free Cash Flow Yield (TTM) | 9.16% | 3.92% |